Careers  |  Sign In  |  Register  |   Twitter

Medtronic’s Artificial Pancreas Approved as Type-1 Diabetes Treatment

Bloomberg News reports that Medtronic Inc. has gained approval for the first artificial pancreas that can be used to regulate blood sugar levels in patients with type-1 diabetes. Typical treatment for type-1 diabetes involves a glucose monitor with which patients can detect blood glucose levels and inject insulin to lower blood sugar. The new device, called MiniMed 530G, can sense when blood glucose levels drop too low and shut off the artificial pancreas. “The MiniMed 530G is the first device approved through a new U.S. Food and Drug Administration program designed to clarify the steps the industry needs to follow to bring a replacement pancreas to the market,” Bloomberg News reports.

Read the article published by Bloomberg News.